• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LI Yan, JIA Huanhuan, HUANG Qing, YUAN Yaozuo, CHEN Minhui, ZHANG Jinlin. Impurity spectra of lansoprazole enteric-coated preparations by high performance liquid chromatography-high resolution orbital trap mass spectrometry[J]. Journal of China Pharmaceutical University, 2023, 54(5): 577-585. DOI: 10.11665/j.issn.1000-5048.2023042601
Citation: LI Yan, JIA Huanhuan, HUANG Qing, YUAN Yaozuo, CHEN Minhui, ZHANG Jinlin. Impurity spectra of lansoprazole enteric-coated preparations by high performance liquid chromatography-high resolution orbital trap mass spectrometry[J]. Journal of China Pharmaceutical University, 2023, 54(5): 577-585. DOI: 10.11665/j.issn.1000-5048.2023042601
shu

Impurity spectra of lansoprazole enteric-coated preparations by high performance liquid chromatography-high resolution orbital trap mass spectrometry

  • 1.

    NMPA Key Laboratory for Impurity Profile of Chemical Drugs, Jiangsu Institute for Food and Drug Control, Nanjing 210019

  • 2.

    School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China

More Information
  • Received Date: April 25, 2023
  • Revised Date: October 17, 2023
    Graphical Abstract
    • Abstract
  • Using high performance liquid chromatography and high resolution orbital trap mass spectrometry, a two-dimensional online desalting detection method was established to determine the structure of the impurities detected under the official testing conditions of lansoprazole enteric solution preparation, and a chromatographic method compatible with mass spectrometry was established to determine and presume the structure of the impurities that could not be separated by the the official testing method.The identification of impurity was to presume its structure according to the presence of impurity reference product, so as to investigate the difference of impurity spectrum of products from different manufacturers.The one-dimensional chromatographic conditions for the 2D online desalting method were the same as those in China Pharmacopoeia (2020) under relevant substances.Two-dimensional chromatography was performed on a Waters C18 T3 column (2.1 mm × 100 mm, 1.7 μm) with 0.1% formic acid in water-acetonitrile mobile phase and gradient elution.The chromatographic conditions for the compatible mass spectra were based on an Agilent Extend C18 (4.6 mm × 150 mm, 5 μm) column with mobile phase A: 25 mmol/L ammonium acetate and B: 25 mmol/L ammonium acetate-acetonitrile (1∶4) [pH adjusted to 6.5 with glacial acetic acid], with gradient elution. Nine impurities were detected by two-dimensional online desalting method, with 5 known impurities (A-E) and 4 unknown ones.14 impurities were detected by the compatible mass spectrometry method, with 9 unknown impurities (4 consistent with the results of two-dimensional online desalting method, and 5 newly detected).The structures and sources of the unknown impurities were deduced.The two detection methods of lansoprazole preparation by high-performance liquid chromatography-high resolution orbital trap mass spectrometry have guiding significance for quality control and process evaluation.
    • FullText(HTML)
    • References (12)
  • [1]
    Zong SY, Wang JK, Xiao Y, et al. Solubility and dissolution thermodynamic properties of lansoprazole in pure solvents[J]. J Mol Liq, 2017, 241: 399-406.
    [2]
    Satoh H. Discovery of lansoprazole and its unique pharmacological properties independent from anti-secretory activity[J]. Curr Pharm Des, 2013, 19(1): 67-75.
    [3]
    Li MH, Feng Q, Li XY, et al. Research progress of clinical applications and adverse reactions of lansoprazole[J]. Chin J Pharmacov (中国药物警戒)，2014,11(12): 729-731.
    [4]
    Gholve SB, Sangshetti JN, Bhusnure OG, et al. RP-HPLC method development and validation for the estimation of lansoprazole in presence of related substances by QbD approach[J]. J Pharm Res Int, 2021, 33(36A): 138-150.
    [5]
    DellaGreca M, Iesce MR, Previtera L, et al. Degradation of lansoprazole and omeprazole in the aquatic environment[J]. Chemosphere, 2006, 63(7): 1087-1093.
    [6]
    British Pharmacopoeia Commission. British Pharmacopoeia[S]. London: Medicines and Healthcare Products Regulatory Agency, 2022.
    [7]
    United States Pharmacopeia Convention. United States Pharmacopeia/ National Formulary [S]. Maryland: The Pharmaceutical Association, 2022.
    [8]
    Chinese Pharmacopoeia Commission. Chinese Pharmacopoeia:part 2 (中华人民共和国药典：二部) [S]. Beijing: China Medical Science Press, 2020: 283-285.
    [9]
    Yang L, Zhang Y, Zhu GF, et al. Synthesis of potential impurities of lansoprazole[J]. Chem Reag (化学试剂), 2020, 42(9): 1120-1124.
    [10]
    Shandilya DK, Israni R, Joseph PE, et al. Identification of oxidative degradation products of lansoprazole by using high resolution mass spectrometry spectral data[J]. Int J Anal Mass Spectrom Chromatogr, 2017, 5(3): 57-69.
    [11]
    Shankar G, Borkar RM, Suresh U, et al. Forced degradation studies of lansoprazole using LC-ESI HRMS and 1H NMR experiments: in vitro toxicity evaluation of major degradation products[J]. J Mass Spectrom, 2017, 52(7): 459-471.
    [12]
    Ramulu K, Rao BM, Rao NS. Identification, isolation and characterization of potential degradation product in lansoprazole drug substance[J]. RASāYAN J Chem, 2013, 6(4): 274-283.
    • Related Articles

  • Related Articles

    [1]NING Manru, XU Kehui, HANG Taijun, SONG Min. Separation and identification of folic acid and its related substances by liquid chromatography-mass spectrometry[J]. Journal of China Pharmaceutical University, 2025, 56(1): 56-64. DOI: 10.11665/j.issn.1000-5048.2024052201
    [2]LI Yue, XU Kai, YANG Rui, YANG Huiying. Application of ultra-high performance convergence chromatography-tandem quadrupole time-of-flight mass spectrometry in the analysis of Span composition[J]. Journal of China Pharmaceutical University, 2024, 55(6): 742-749. DOI: 10.11665/j.issn.1000-5048.2024010502
    [3]JIA Yifei, WANG Yamei, LI Gongyu. Recent progress of protein glycosylation characterization utilizing native conformer-resolved mass spectrometry[J]. Journal of China Pharmaceutical University, 2023, 54(6): 674-681. DOI: 10.11665/j.issn.1000-5048.2023060901
    [4]WANG Songkai, ZOU Yuchen, SUN Shipeng, YAN Zhiye, TANG Weiwei, LI Ping, LI Bin. Recent advances in mass spectrometry imaging and its application in drug research[J]. Journal of China Pharmaceutical University, 2023, 54(6): 653-661. DOI: 10.11665/j.issn.1000-5048.2023091901
    [5]YU Lili, CHU Tingting, HOU Chenzhi, WANG Youmei, DI Bin. Quantitative determination of 10 illicit drugs in wastewater by liquid-liquid extraction-ultra performance liquid chromatography-tandem mass spectrometry[J]. Journal of China Pharmaceutical University, 2021, 52(6): 707-712. DOI: 10.11665/j.issn.1000-5048.20210608
    [6]CHEN Yiling, FENG Jiangjiang, YANG Haixue, SHI Yaping, LI Longnan, FENG Fang. Determination of genotoxic impurities of alkyl methanesulfonates in methanesulfonic acid by gas chromatography–mass spectrometry[J]. Journal of China Pharmaceutical University, 2020, 51(4): 472-478. DOI: 10.11665/j.issn.1000-5048.20200413
    [7]LUAN Baolei, XU Xinjun, LIANG Guiting, YOU Mengmeng, LIU Guozhu. Determination of related genotoxic impurities in olmesartan medoxomil by HPLC-MS[J]. Journal of China Pharmaceutical University, 2019, 50(3): 325-329. DOI: 10.11665/j.issn.1000-5048.20190308
    [8]CAO Guoxiu, LU Wenjie, YE Hui, TIAN Yang, HAO Haiping. Rapid identification of constituents from different Ginkgo biloba preparations by high resolution mass spectrometry and metabolomics technology[J]. Journal of China Pharmaceutical University, 2018, 49(4): 441-448. DOI: 10.11665/j.issn.1000-5048.20180409
    [9]LI Xinxin, CHEN Linfei, OUYANG Yongzhong, CHEN Huanwen, FENG Fang. Mass spectrometry assessment of the protective effects of Zhizi Dahuang decoction on alcoholic liver injury[J]. Journal of China Pharmaceutical University, 2015, 46(5): 579-586. DOI: 10.11665/j.issn.1000-5048.20150511
    [10]LI Xinxin, WU Huan, WANG Chen, FENG Fang. Mass spectrometry imaging and its application in pharmaceutical sciences[J]. Journal of China Pharmaceutical University, 2014, 45(1): 17-25. DOI: 10.11665/j.issn.1000-5048.20140103

Catalog

    Get Citation
    PDF
    XML
    Article views (138) PDF downloads (292) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：299203

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return